Home>Topics>Funds>iShares S&P Global Healthcare

iShares S&P Global Healthcare IXJ

  1. All
  2. Commentary
  3. Fund Reports
  4. ETF Reports
  5. Headlines
    1. Ebola outbreak in West Africa uncontained

      Headlines

      Fri, 11 Jul 2014

      mortality rate is as high as 90%. It is spread by close contact with the body fluids and tissues of infected people. There is no treatment or vaccine available. ETFs: BBRC , EMBB ETFs: IBB , BIB , IRY , IXJ , BIS , DRGS Post your comment!

    2. Omega Pharma reportedly mulling sale

      Headlines

      Mon, 7 Jul 2014

      Bloomberg reports that privately-held Omega Pharma N.V. is exploring a sale of the company for as much as $4B. The Belgian firm was taken private ~three years ago by the founder. ETFs: IBB , BIB , IRY , IXJ , BIS , EWK , DRGS Post your comment!

    3. IHE iShares US Pharmaceuticals ETF Analysis, Report, Research, 5 Star Rating – Morningstar

      ETF Reports

      Mon, 5 May 2014

      0.14%. And investors seeking international pharmaceutical exposure should consider investing in iShares Global Healthcare IXJ , which has a 0.48% expense ratio and invests about 38% of its assets in foreign-domiciled firms. This ETF passively tracks

    4. IHE iShares US Pharmaceuticals ETF Analysis, Report, Research, 5 Star Rating – Morningstar

      ETF Reports

      Mon, 5 May 2014

      of 0.14%. And investors seeking international pharmaceutical exposure should consider investing in iShares S & P Global Healthcare IXJ , which has a 0.48% expense ratio and invests about 38% of its assets in foreign-domiciled firms

    5. XPH SPDR S&P Pharmaceuticals ETF ETF Analysis, Report, Research, 5 Star Rating – Morningstar

      ETF Reports

      Mon, 5 May 2014

      correlated with that of XPH. Investors seeking international pharmaceutical exposure should consider iShares Global Health Care ETF IXJ , which has a 0.48% expense ratio and invests more than 37% of its assets in foreign-domiciled firms. This exchange

    6. IXJ iShares Global Healthcare ETF Analysis, Report, Research, 5 Star Rating – Morningstar

      ETF Reports

      Wed, 23 Apr 2014

      The SPDR sports a 96% correlation with IXJ over the past five years, while the Vanguard ..... has a 95% performance correlation with IXJ over that time frame. These high correlations ..... can consider iShares Global Healthcare ETF IXJ . Given the sector's lack of economic

    7. IYH iShares US Healthcare ETF Analysis, Report, Research, 5 Star Rating – Morningstar

      ETF Reports

      Wed, 12 Mar 2014

      their health-care exposure also can consider iShares S & P Global Healthcare IXJ (0.48% expense ratio), which invests about ..... domiciled firms. The performance of IYH and IXJ has been 96% correlated over the past 10 years

    8. VHT Vanguard Health Care ETF ETF Analysis, Report, Research, 5 Star Rating – Morningstar

      ETF Reports

      Wed, 12 Mar 2014

      expense ratio), iShares U.S. Healthcare IYH (0.45% expense ratio), and iShares Global Healthcare IXJ (0.48%). XLV, IYH, and IXJ sport respective correlations of 99%, 100%, and 95% with Vanguard Health Care over the past five years

    9. XLV Health Care Select Sector SPDR® ETF Analysis, Report, Research, 5 Star Rating – Morningstar

      ETF Reports

      Wed, 12 Mar 2014

      Fidelity. Investors seeking some international flavor for their health-care exposure should consider iShares Global Health Care IXJ (0.48%), as it invests 38% of assets in foreign-domiciled firms. Those seeking exposure only to those firms domiciled

    10. FXH First Trust Health Care AlphaDEX ETF Analysis, Report, Research, 5 Star Rating – Morningstar

      ETF Reports

      Tue, 11 Mar 2014

      operators. Investors seeking some international flavor for their health-care exposure should consider iShares Global Healthcare IXJ (0.48%), as it invests 38% of assets in foreign-domiciled firms. Those seeking exposure only to those firms domiciled

    « Prev1234Next »
    Content Partners